Efficacy and Safety Study of Gantenerumab in Participants With Early Alzheimer's Disease (AD)

Neurodegenerative Disorder
Alzheimer's Disease (AD)

Results
Download
Print

Study results

LPS WN29922 GRADUATE I Final Results November 2023 English (PDF, 0.8 MB)

LPS WN29922 GRADUATE I Final Results November 2023 Spain Spanish (PDF, 0.7 MB)

LPS WN29922 GRADUATE I Final Results November 2023 Russian (PDF, 0.5 MB)

LPS WN29922 GRADUATE I Final Results November 2023 French (PDF, 0.8 MB)

LPS WN29922 GRADUATE I Final Results November 2023 German (PDF, 0.6 MB)

LPS WN29922 GRADUATE I Final Results November 2023 Japanese (PDF, 0.5 MB)

What is Clinical Research?

In clinical research, volunteers, researchers, and medical professionals work together toward a shared goal: better treatment outcomes for patients. Clinical trials are vital to their process. They are carefully designed and follow approved protocols.

Efficacy and Safety Study of Gantenerumab in Participants With Early Alzheimer's Disease (AD)

Study results

LPS WN29922 GRADUATE I Final Results November 2023 English (PDF, 0.8 MB)

LPS WN29922 GRADUATE I Final Results November 2023 Spain Spanish (PDF, 0.7 MB)

LPS WN29922 GRADUATE I Final Results November 2023 Russian (PDF, 0.5 MB)

LPS WN29922 GRADUATE I Final Results November 2023 French (PDF, 0.8 MB)

LPS WN29922 GRADUATE I Final Results November 2023 German (PDF, 0.6 MB)

LPS WN29922 GRADUATE I Final Results November 2023 Japanese (PDF, 0.5 MB)

What is Clinical Research?

For the latest version of this information please go to www.forpatients.roche.com

Directly contact Roche for questions

Contact the hospital directly

Thank you

Something went wrong

Request a call back

Find participating medical centers and current study status in each of them

Efficacy and Safety Study of Gantenerumab in Participants With Early Alzheimer's Disease (AD)

For the latest version of this information please go to www.forpatients.roche.com